Apoptosis and release of CD44s in bleomycin-treated L132 cells

Journal of Cellular Biochemistry

Volumn 95, Issue 6, 2005, Pages 1146-1156

  Koslowski, R ^a,b   Fichtner, F ^a   Barth, K ^a   Roehlecke, C ^a   Seidel, D ^a   Kasper, M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Apoptosis; Bleomycin; CD44; Fibrosis; Pulmonary epithelial cells

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BLEOMYCIN; CASPASE 3; CYTOCHROME C; FAS ANTIGEN; HERMES ANTIGEN; HYALURONIC ACID;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL KINETICS; COLON CARCINOMA; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; LUNG INJURY; PRIORITY JOURNAL; SUPERNATANT;

ANTIGENS, CD44; APOPTOSIS; BLEOMYCIN; CASPASE 3; CASPASES; CELL LINE; CYTOCHROMES C; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; KINETICS; MICROSCOPY, IMMUNOELECTRON; REACTIVE OXYGEN SPECIES; SOLUBILITY;

EID: 26444469669     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20483     Document Type: Article

References (42)

1. Ayroldi E, Cannarile L, Migliorati G, Bartoli A, Nicoletti I, Riccardi C. 1995. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis. Blood 86:2672-2678.
2. Burger RM, Projan SJ, Horwitz SB, Peisach J. 1986. The DNA cleavage mechanism of iron-bleomycin. Kinetic resolution of strand scission from base propenal release. J Biol Chem 261:15955-15959.
3. Cichy J, Pure E. 2003. The liberation of CD44. J Cell Biol 161:839-843.
4. Cichy J, Bals R, Potempa J, Mani A, Pure E. 2002. Proteinase-mediated release of epithelial cell-associated CD44. Extracellular CD44 complexes with components of cellular matrices. J Biol Chem 277:44440-44447.
5. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C, Silorski E. 1990. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 111:2765-27674.
6. Ghosh S, Mendoza T, Ortiz LA, Hoyle GW, Fermin CD, Brody AR, Friedman M, Morris GF. 2002. Bleomycin sensitivity of mice expressing dominant-negative p53 in the lung epithelium. Am J Respir Crit Care Med 166:890-897.
7. Gimonet D, Landais E, Bobichon H, Coninx P, Liautaud-Roger F. 2004. Induction of apoptosis by bleomycin in p53-null HL-60 leukemia cells. Int J Oncol 24:313-319.
8. Goodison S, Urquidi V, Tarin D. 1999. CD44 cell adhesion molecules. Mol Pathol 52:189-196.
9. Green SJ, Tarone G, Underhill CB. 1988. Distribution of hyaluronate and hyaluronate receptors in the adult lung. J Cell Sci 90(Pt 1):145-156.
10. Gunthert AR, Strater J, von Reyher U, Henne C, Joos S, Koretz K, Moldenhauer G, Krammer PH, Moller P. 1996. Early detachment of colon carcinoma cells during CD95 (APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44. J Cell Biol 134:1089-1096.
11. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N. 1997. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 16:91-101.
12. Hong JS, Ko HH, Han ES, Lee CS. 2003. Inhibition of bleomycin-induced cell death in rat alveolar macrophages and human lung epithelial cells by ambroxol. Biochem Pharmacol 66:1297-1306.
13. Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, Krammer PH, Galle PR. 1997. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem 272:28191-29193.
14. Jones DT, Ganeshaguru K, Virchis AE, Folarin NI, Lowdell MW, Mehta AB, Prentice HG, Hoffbrand AV, Wickremasinghe RG. 2001. Caspase 8 activation independent of Fas (CD95/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation. Blood 98:2800-2807.
15. Kasper M, Gunthert U, Dall P, Kayser K, Schuh D, Haroske G, Muller M. 1995. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am J Respir Cell Mol Biol 13:648-656.
16. Kasper M, Bierhaus A, Whyte A, Binns RM, Schuh D, Muller M. 1996. Expression of CD44 isoforms during bleomycin- or radiation-induced pulmonary fibrosis in rats and mini-pigs. Histochem Cell Biol 105:221-230.
17. Koslowski R, Pfeil U, Fehrenbach H, Kasper M, Skutelsky E, Wenzel KW. 2001. Changes in xylosyl-transferase activity and in proteoglycan deposition in bleomycin-induced lung injury in rat. Eur Respir J 18:347-356.
18. Koslowski R, Knoch K, Kuhlisch E, Seidel D, Kasper M. 2003. Cathepsins in bleomycin-induced lung injury in rat. Eur Respir J 22:427-435.
19. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N. 1996. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 154:477-483.
20. Kuwano K, Hagimoto N, Kawasaki M, Yatomi T, Nakamura N, Nagata S, Suda T, Kunitake R, Maeyama T, Miyazaki H, Hara N. 1999. Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis. J Clin Invest 104:13-19.
21. Kuwano K, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, Kaneko Y, Matsuba T, Maeyama T, Hara N. 2000. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 190:221-229.
22. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N. 2001. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 280:L316-L325.
23. Lazaar AL, Plotnick MI, Kucich U, Crichton I, Lotfi S, Das SK, Kane S, Rosenbloom J, Panettieri RA, Jr., Schechter NM, Pure E. 2002. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol 169:1014-1020.
24. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, Bevilacqua C, Facchini A. 2001. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 44:1800-1807.
25. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Gunthert U. 1994. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82.
26. Menzel EJ, Farr C. 1998. Hyaluronidase and its substrate hyaluronan: Biochemistry, biological activities and therapeutic uses. Cancer Lett 131:3-11.
27. Muller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH, Galle PR. 1997. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413.
28. Muller M, Wilder S, Bannasch D, Israeli D, Lehlbach K, Li-Weber M, Friedman SL, Galle PR, Stremmel W, Oren M, Krammer PH. 1998. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J Exp Med 188:2033-2045.
29. Peterson RM, Yu Q, Stamenkovic I, Toole BP. 2000. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am J Pathol 156:2159-2167.
30. Ramp U, Dejosez M, Mahotka C, Czarnotta B, Kalinski T, Wenzel M, Lorenz I, Muller M, Krammer P, Gabbert HE, Gerharz CD. 2000. Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: A potential factor of multidrug resistance in human renal cell carcinoma. Br J Cancer 82:1851-1859.
31. Ristamaki R, Joensuu H, Lappalainen K, Teerenhovi L, Jalkanen S. 1997. Elevated serum CD44 level is associated with unfavorable outcome in non-Hodgkin's lymphoma. Blood 90:4039-4045.
32. Roehlecke C, Kuhnt AK, Fehrenbach H, Werner C, Funk RH, Kasper M. 2000. Resistance of L132 lung cell clusters to glyoxal-induced apoptosis. Histochem Cell Biol 114:283-292.
33. Schulze E, Witt M, Kasper M, Lowik CW, Funk RH. 1999. Immunohistochemical investigations on the differentiation marker protein E11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2. 8. Histochem Cell Biol 111:61-69.
34. Sutherland LM, Edwards YS, Murray AW. 2001. Alveolar type II cell apoptosis. Comp Biochem Physiol A Mol Integr Physiol 129:267-285.
35. Svee K, White J, Vaillant P, Jessurun J, Roongta U, Krumwiede M, Johnson D, Henke C. 1996. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. J Clin Invest 98:1713-1727.
36. Takazoe K, Tesch GH, Hill PA, Hurst LA, Jun Z, Lan HY, Atkins RC, Nikolic-Paterson DJ. 2000. CD44-mediated neutrophil apoptosis in the rat. Kidney Int 58:1920-1930.
37. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW. 2002. Resolution of lung inflammation by CD44. Science 296:155-158.
38. Terpe HJ, Stark H, Prehm P, Gunthert U. 1994. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues. Histochemistry 101:79-89.
39. Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, Flynn K, Filippatos G. 1998. Captopril inhibits apoptosis in human lung epithelial cells: A potential antifibrotic mechanism. Am J Physiol 275:L1013-L1017.
40. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. 2000. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 279:L143-L151.
41. Yasuda M, Tanaka Y, Fujii K, Yasumoto K. 2001. CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int Immunol 13:1309-1319.
42. Zhao HW, Hu SY, Barger MW, Ma JK, Castranova V, Ma JY. 2004. Time-dependent apoptosis of alveolar macrophages from rats exposed to bleomycin: Involvement of tnf receptor 2. J Toxicol Environ Health A 67:1391-1406.